Moody Aldrich Partners’s Ascendis Pharma A/S ASND Stock Holding History

Moody Aldrich Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$332K	Sell	1,246 -3	-0.2%	-$701	0.06%	144
2026 Q1	$286K	Sell	1,249 -27	-2%	-$6.05K	0.05%	169
2025 Q4	$272K	Sell	1,276 -4	-0.3%	-$826	0.05%	163
2025 Q3	$254K	Sell	1,280 -5	-0.4%	-$933	0.05%	161
2025 Q2	$222K	Buy	+1,285	New	+$209K	0.04%	168
2024 Q4	–	Sell	-1,520	Closed	-$227K	–	202
2024 Q3	$227K	Sell	1,520 -3	-0.2%	-$405	0.04%	184
2024 Q2	$208K	Hold	1,523	–	–	0.04%	191
2024 Q1	$230K	Buy	+1,523	New	+$217K	0.04%	200
2020 Q3	–	Sell	-22,690	Closed	-$3.36M	–	157
2020 Q2	$3.36M	Buy	22,690 +8,987	+66%	+$1.23M	0.71%	63
2020 Q1	$1.54M	Sell	13,703 -4,442	-24%	-$577K	0.47%	79
2019 Q4	$2.52M	Buy	+18,145	New	+$2.02M	0.52%	79

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Moody Aldrich Partners's ASND Position: Q2 2026 in Review

Moody Aldrich Partners reduced its Ascendis Pharma A/S (ASND) stake by 0.24% in Q2 2026, selling an estimated $701 and leaving 1,246 shares worth $332K. The position accounts for 0.06% of the portfolio, ranked #144.

Moody Aldrich Partners first reported a position in ASND in Q4 2019 and has held it in 11 quarters since. The position peaked at $3.36M in Q2 2020. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Moody Aldrich Partners held 1,246 shares of Ascendis Pharma A/S worth $332K as of Q2 2026.
Moody Aldrich Partners sold 3 Ascendis Pharma A/S shares in Q2 2026, an estimated $701.
Ascendis Pharma A/S made up 0.06% of Moody Aldrich Partners's portfolio in Q2 2026, its #144 holding.
Moody Aldrich Partners first reported a position in Ascendis Pharma A/S in Q4 2019 and has held it in 11 quarters since.
Moody Aldrich Partners's Ascendis Pharma A/S position peaked at $3.36M in Q2 2020.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.